Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 3Ganglioneuroblastoma 2Wilms Tumor 1Rhabdoid Tumor 1Pyloric Stenosis, Hypertrophic 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Medulloblastoma 1Kidney Neoplasms 1

Interventions

Temozolomide 3Cyclophosphamide 3Etoposide 2ibrutinib 1gallium Ga 68 dotatate 1fludarabine 1etoposide phosphate 1belzutifan 1Zoledronic Acid 1Vincristine 1Thiotepa 1Tamoxifen 1Standard of Care 1Radiotherapy 1ONC206 1Nivolumab 1Mesna 1Isotretinoin 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Eflornithine 1Drug Therapy 1Cisplatin 1Celecoxib 1Carboplatin 1Blood Specimen Collection 1Automobiles 11-methyltryptophan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neuroectodermal Tumors, Primitive × Isotretinoin × Clear all
NCT06942039 2026-02-27

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

C17 Council

Phase EARLY_PHASE1 Recruiting
15 enrolled
CNS

Medulloblastoma, Neuroblastoma, Pinealoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor, Pyloric Stenosis, Hypertrophic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡